Strong Induction of p73 Protein In Vivo Coincides With the Onset of Apoptosis in Rat Liver After Treatment With the Hepatocarcinogen N-Nitrosomorpholine (NNM)

Journal of Cellular Biochemistry

Volumn 90, Issue 4, 2003, Pages 837-855

  Tudzarova Trajkovska, Slavica ^a   Wȩsierska Ga̧dek, Józefa ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Activation of NF B; Caspase activation; Cytochrome C release; p53 response; PARP 1 cleavage; TUNEL assay

Indexed keywords

APOPTOSIS INDUCING FACTOR; GENE PRODUCT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITROSOMORPHOLINE; PROTEIN MDM2; PROTEIN P53; PROTEIN P73;

ALPHA CHAIN; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BETA CHAIN; CONTROLLED STUDY; DNA REPAIR; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; SIGNAL TRANSDUCTION; TESTIS;

ANIMALS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL NUCLEUS; CYTOCHROMES C; DNA REPAIR; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GENES, TUMOR SUPPRESSOR; HUMANS; KINETICS; LIVER; MALE; MITOCHONDRIA; MORPHOLINES; NF-KAPPA B; NUCLEAR PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN TRANSPORT; RATS; RATS, WISTAR; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0242695558     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10678     Document Type: Article

References (57)

1. Agami R, Blandino G, Oren M, Shaul Y. 1999. Interaction of c-Abl and p73 and their collaboration to induce apoptosis. Nature 399:809-813.
2. Bellamy CO, Clarke AR, Wyllie AH, Harrison DJ. 1997. p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J 11:591-599.
3. Brambilla G, Carlo P, Finollo R, Sciaba L. 1987. Dose-response curves for DNA fragmentation induced in rats by sixteen N-nitroso compounds as measured by viscometric and alkaline elution analyses. Cancer Res 47:3485-3491.
4. Bravo R, Macdonald-Bravo H. 1987. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 105:1549-1554.
5. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. 1987. Cyclin/PCNA is the auxiliary protein of DNA polymerase. Nature 326:515-517.
6. Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, Zamzami N, Kroemer G. 2000. Apoptosis-inducing factor (AIF): A ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476:118-123.
7. De Laurenzi V, Constanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M, Melino G. 1998. Two new p73 splice variants, γ and δ, with different transcriptional activity. J Exp Med 188:1763-1768.
8. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. 1992. Definition of a consensus binding site for p53. Nat Genet 1:45-49.
9. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF-1, a potential mediator of p53 tumour suppression. Cell 75:17-825.
10. Enzmann H, Bannasch P. 1987. Morphometric study of alterations of extrafocal hepatocytes of rat liver treated with N-nitrosomorpholine. Virchows Arch B Cell Pathol Incl Mol Pathol 53:218-226.
11. Fang L, Lee SW, Aaronson SA. 1999. Comparative analysis of p73 and p53 regulation and effector functions. J Cell Biol 147:823-830.
12. Fiskum G, Kowaltowksi AJ, Andreyev AY, Kushnareva YE, Starkov AA. 2000. Apoptosis-related activities measured with isolated mitochondria and digitonin-permeabilized cells. Methods Enzymol 322:222-234.
13. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T. 2002. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416:560-564.
14. Fontemaggi G, Kela I, Amariglio N, Rechavi G, Krishnamurthy J, Strano S, Sacchi A, Givol D, Blandino G. 2002. Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses. J Biol Chem 277:43359-43368.
15. Froelich CJ, Hanna WL, Poirier GG, Duriez PJ, D'Amours D, Salvesen GS, Alnemri ES, Earnshaw WC, Shah GM. 1996. Granzyme B/perforin mediated apoptosis of Jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDA fragment. Biochem Biophys Res Commun 227:658-665.
16. Gong J, Costanzo A, Yang H.-Q, Melino G, Kaelin WG Jr, Levrero M, Wang JYJ. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806-809.
17. Halazonetis TD, Davis LJ, Kandil AN. 1993. Wild-type p53 adopts a"mutant"-like conformation when bound to DNA. EMBO J 12:1021-1028.
18. Harris CC. 1996. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88:1442-1445.
19. Herath NI, Kew MC, Whitehall VLJ, Walsh MD, Jass JR, Khanna KK, Young J, Powell LW, Leggett BA, Macdonald GA. 2000. p73 is up-regulated in a subset of hepatocellular carcinomas. Hepatology 31:601-605.
20. Ikawa S, Nakagawara A, Ikawa Y. 1999. p53 family genes: Structural comparison, expression and mutation. Cell Death Differ 6:1154-1161.
21. Jackson P, Ridgway P, Rayner J, Noble J, Braithwaite A. 1994. Transcriptional regulation of the PCNA promoter by p53. Biochem Biophys Res Commun 203:133-140.
22. Jones RA, Johnson VL, Hinton RH, Poirier GG, Chow SC, Kass GEN. 1999. Liver poly(ADP-ribose)polymerase is resistant to cleavage by caspases. Biochem Biophys Res Commun 256:436-441.
23. Jost CA, Marin MC, Kaelin WG, Jr. 1997. p73 is a human p53-related protein that can induce apoptosis. Nature 389:191-194.
24. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong YY, Mak TW, Zuniga-Pflucker JC, Kroemer G, Penninger JM. 2001. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410:549-554.
25. Kaelin WG, Jr. 1999. The emerging p53 gene family. J Natl Cancer Inst 91:594-598.
26. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-829.
27. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587-597.
28. Kelman Z. 1997. PCNA: Structure, functions and interactions. Oncogene 14:629-640.
29. Ko LJ, Prives C. 1996. p53: Puzzled and paradigm. Genes Dev 10:1054-1072.
30. Kovar H, Jug G, Printz D, Schmid G, Wesierska-Gadek J. 2000. Characterization of dictinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8. Oncogene 19:4096-4107.
31. Lee C-W, La Thangue NB. 1999. Promoter specificity and stability control of the p53-related protein p73. Oncogene 18:4171-4181.
32. Levrero M, De Laurenzi V, Costanzo A, Gong J, Melino G, Wang JYJ. 1999. Structure, function and regulation of p63 and p73. Cell Death Differ 6:1146-1153.
33. Manson D, Cox PJ, Jarman M. 1978. Metabolism of N-nitrosomorpholine by the rat in vivo and by rat liver microsomes and its oxidation by the Fenton system. Chem Biol Interact 20:341-354.
34. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. 1992. The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
35. Moore MA, Mayer D, Bannasch P. 1982. The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis 3:1429-31436.
36. Morris GF, Bischoff JR, Mathews MB. 1996. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc Natl Acad Sci USA 93:895-899.
37. Nakano K, Balint E, Ashkroft M, Vousden KH. 2000. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene 19:4283-4289.
38. Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M, Ikawa S. 1998. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 4:839-843.
39. Rubbi CP, Milner J. 2000. Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus. Oncogene 19:85-96.
40. Sakaguchi K, Sakamoto H, Lewis MS, Anderson CW, Erickson JW, Appella E, Xie D. 1997. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36:10117-10124.
41. Shimodaira H, Yoshioka-Yamashita A, Kolodner RD, Wang JY. 2003. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci USA 100:2420-2425.
42. Shivji MKK, Kenny MK, Wood RD. 1992. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69:367-374.
43. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ, Jr. 1994. Interaction of the p53-regulated protein Gadd 45 with proliferating cell nuclear antigen. Science Washington DC 266:1376-1380.
44. Stewart BW, Hicks RM, Magee PN. 1975. Acute biochemical and morphological effects of N-nitrosomorpholine in comparison to dimethyl- and diethyl-nitrosamine. Chem Biol Interact 11:413-429.
45. Sutton VR, Wowk ME, Cancilla M, Trapani JA. 2003. Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. Immunity 18:319-329.
46. Tamm I, Schriever F, Doerken B. 2001. Apoptosis: Implications of basic research for clinical oncology. Lancet Oncol 2:33-42.
47. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y, Nakamura Y. 2000. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404:42-49.
48. Tata JR. 1974. Isolation of nuclei from rat liver and other tissues. Methods Enzymol 31:253-262.
49. Thorgeirsson SS, Teramoto T, Factor VM. 1998. Dysregulation of apoptosis in hepatocellular carcinoma. Semin Liver Dis 18:115-122.
50. Urist M, Prives C. 2002. p53 leans on its siblings. Cancer Cell 1:311-313.
51. Vikhanskaya F, D'Incalci M, Broggini M. 2000. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line. Nucleic Acids Res 28:513-519.
52. Weber E, Bannasch P. 1994. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine. Carcinogenesis 15:1235-1242.
53. Wesierska-Gadek J, Grimm R, Hitchman E, Penner E. 1998. Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology 114:329-335.
54. Wesierska-Gadek J, Bugajska-Schretter A, Löw-Baselli A, Grasl-Kraupp B. 1999. Cleavage of poly(ADP-ribose) transferase during p53-independent apoptosis in rat liver after treatment with N-nitrosomorpholine and cyproterone acetat. Mol Carcinog 24:263-275.
55. Wirnitzer U, Enzmann H, Rosenbruch M, Bomhard EM. 1995. Accumulation of p53 protein in chemically induced oval cells during early stages of rodent hepatocarcinogenesis. Carcinogenesis 16:697-701.
56. Yamaizumi M, Sugano T. 1994. U.V. induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle. Oncogene 9:2775-2784.
57. Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R, Kufe D. 1999. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399:814-817.